Challenges and opportunities in the management of metastatic renal cell carcinoma: combination therapy and the role of cytoreductive surgery
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference46 articles.
1. Cancer statistics;Siegel;CA Cancer J Clin,2020
2. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma;Zisman;J Clin Oncol,2002
3. Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma;Nerich;Onco Targets Ther,2014
4. Von Hippel-Lindau (VHL) inactivation in sporadic clear cell renal cancer: associations with germline VHL polymorphisms and etiologic risk factors;Moore;PLoS Genet,2011
5. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing;Ivan;Science,2001
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bispecific fibrous glue synergistically boosts vascular normalization and antitumor immunity for advanced renal carcinoma therapy;Biomaterials;2024-07
2. The role of RNA-modifying proteins in renal cell carcinoma;Cell Death & Disease;2024-03-19
3. The emerging genetic landscape of renal cell carcinoma;Diagnostic Molecular Pathology;2024
4. PD 1: A Trending Target in Anti-cancer Research;BIOINTERFACE RES APP;2023
5. A Science-Based Methodology Framework for the Assessment of Combination Safety Risks in Clinical Trials;Pharmaceutical Medicine;2023-04-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3